日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Medicare for All: Considerations for Neuroradiologists

全民医保:神经放射科医生的考量

Nguyen, T H; Milburn, J M; Duszak, R; Savoie, J; Horný, M; Hirsch, J A

Salivary and urinary metabolome analysis for pre-puberty-related biomarkers identification in porcine.

猪唾液和尿液代谢组分析用于鉴定青春期前相关生物标志物

Goudet G, Nadal-Desbarats L, Douet C, Savoie J, Staub C, Venturi E, Ferchaud S, Boulot S, Prunier A

A phase II study of ixabepilone and trastuzumab for metastatic HER2-positive breast cancer

一项针对转移性 HER2 阳性乳腺癌的 ixabepilone 和 trastuzumab 的 II 期研究

Tolaney, S M; Najita, J; Sperinde, J; Huang, W; Chen, W Y; Savoie, J; Fornier, M; Winer, E P; Bunnell, C; Krop, I E

A randomized controlled trial of oral melatonin supplementation and breast cancer biomarkers

一项关于口服褪黑素补充剂与乳腺癌生物标志物的随机对照试验

Schernhammer, E S; Giobbie-Hurder, A; Gantman, K; Savoie, J; Scheib, R; Parker, L M; Chen, W Y

Outcomes following HSCT using fludarabine, busulfan, and thymoglobulin: a matched comparison to allogeneic transplants conditioned with busulfan and cyclophosphamide

使用氟达拉滨、白消安和胸腺球蛋白进行 HSCT 的结果:与使用白消安和环磷酰胺进行处理的同种异体移植的匹配比较

Christopher N Bredeson, Mei-Jie Zhang, Manza-A Agovi, Andrea Bacigalupo, Nizar J Bahlis, Karen Ballen, Christopher Brown, M Ahsan Chaudhry, Mary M Horowitz, Seira Kurian, Diana Quinlan, Catherine E Muehlenbien, James A Russell, Lynn Savoie, J Douglas Rizzo, Douglas A Stewart

Studies on mono- and diiodohistidine. II. Congenital goitrous hypothyroidism with thyroglobulin defect and iodohistidine-rich iodoalbumin production

单碘组氨酸和二碘组氨酸的研究。II. 先天性甲状腺肿性甲状腺功能减退症伴甲状腺球蛋白缺陷和富含碘组氨酸的碘白蛋白生成

Savoie, J C; Massin, J P; Savoie, F

Studies on mono- and diiodohistidine. I. The identification of iodohistidines from thyroidal iodoproteins and their peripheral metabolism in the normal man and rat

单碘组氨酸和二碘组氨酸的研究。I. 从甲状腺碘蛋白中鉴定碘组氨酸及其在正常人和大鼠体内的外周代谢

Savoie, J C; Thomopoulos, P; Savoie, F